Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT00000918
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are over 13 years old (need consent of parent or guardian if under 18).
* Are HIV-positive.
* Currently have virologic failure (more than 1,000 copies of HIV RNA per ml).
* Agree to abstinence or use of effective birth control during the study.
* Have been taking NFV for the past 12 weeks.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have a fever for 7 days or diarrhea for 30 days before study entry.
* Have a history of peripheral neuropathy within 60 days of study entry.
* Have hepatitis.
* Have any malignancy (cancer) other than minimal Kaposi's sarcoma.
* Are pregnant or breast-feeding.
* Are receiving radiation, chemotherapy, or any therapy for any illness within 14 days of study entry.
* Have taken amprenavir, saquinavir, indinavir or ritonavir for more than 7 days.
* Have received an HIV vaccine 30 days before study entry.
* Are receiving certain other medications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT00000918
Study Brief:
Protocol Section:
NCT00000918